A Study of CS1002 in Subjects With Advanced Solid Tumors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a multicenter, open-label, multiple dose, dose escalation phase I study to evaluate the clinical safety, tolerability, PK, and preliminary anti-tumor efficacy of CS1002.
Epistemonikos ID: 89287e6357385d2e6143e08d62cbd0d0eda23e3e
First added on: May 21, 2024